The Cholestatic and Autoimmune Liver Diseases Special Interest Group (SIG) is an international community of investigators and practitioner focusing on preventing diagnosing and treating cholestatic liver diseases, as well as diseases of the biliary tree (choangiopathies). The SIG also strongly focuses on understanding the pathophysiology and on the genetics of cholestatic and biliary diseases as a way to identify novel therapeutic targets. The SIG promotes national and international collaborations and networks and registries to speed up the rate of discoveries and to facilitate clinical trials in an area that includes several rare diseases.


Watch the video recording [MP4] from their recent business meeting to learn what their focus will be in 2019.

Communications Subcommittee

  • Chair: Nanda Kerkar, MD, FAASLD
  • Member: Marina G. Silveira, MD
  • Member: Aldo J. Montano-Loza, MD, PhD, FAASLD
  • Member: Muyiwa Awoniyi, MD, PhD
  • Member: Ariane Therien, MSc

Education Subcommittee

  • Chair: VACANT
  • Vice-Chair: Huiping Zhou, PhD
  • Member: Girish S. Rao, MD
  • Member: Uzma Shah, MD, FAAP
  • Member: John E. Eaton, MD
  • Member: Nora Cazzagon, MD

Global Outreach Subcommittee

  • Chair: Luca Fabris, MD, PhD
  • Member: Gilda Porta, MD, PhD
  • Member: Josh Levitsky, MD, FAASLD
  • Member: Michele M. Tana, MD
  • Member: Carlos Noronha Ferreira, MD
  • Member: Ansgar W. Lohse, MD

Membership and Mentorship Subcommittee

  • Chair: VACANT
  • Member: James F. Daniel, MD, FAASLD
  • Member: James H. Tabibian, MD, PhD
  • Member: Ehab Ahmed Abdelatty, MD
  • Member: Yoshiyuki Ueno, MD, PhD, FAASLD